Apoptosis_NN
mediated_VBN
by_IN
HIV_NN
protease_NN
is_VBZ
preceded_VBN
by_IN
cleavage_NN
of_IN
Bcl-2_NN
._.

Expression_NN
of_IN
the_DT
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
-LRB-_-LRB-
HIV_NN
-RRB-_-RRB-
protease_NN
in_IN
cultured_VBN
cells_NNS
leads_VBZ
to_TO
apoptosis_NN
,_,
preceded_VBN
by_IN
cleavage_NN
of_IN
bcl-2_NN
,_,
a_DT
key_JJ
negative_JJ
regulator_NN
of_IN
cell_NN
death_NN
._.

In_IN
contrast_NN
,_,
a_DT
high_JJ
level_NN
of_IN
bcl-2_NN
protects_VBZ
cells_NNS
in_FW
vitro_FW
and_CC
in_FW
vivo_FW
from_IN
the_DT
viral_JJ
protease_NN
and_CC
prevents_VBZ
cell_NN
death_NN
following_VBG
HIV_NN
infection_NN
of_IN
human_JJ
lymphocytes_NNS
,_,
while_IN
reducing_VBG
the_DT
yields_NNS
of_IN
viral_JJ
structural_JJ
proteins_NNS
,_,
infectivity_NN
,_,
and_CC
tumor_NN
necrosis_NN
factor_NN
alpha_NN
._.

We_PRP
present_VBP
a_DT
model_NN
for_IN
HIV_NN
replication_NN
in_IN
which_WDT
the_DT
viral_JJ
protease_NN
depletes_VBZ
the_DT
infected_JJ
cells_NNS
of_IN
bcl-2_NN
,_,
leading_VBG
to_TO
oxidative_JJ
stress-dependent_NN
activation_NN
of_IN
NF_NN
kappa_NN
B_NN
,_,
a_DT
cellular_JJ
factor_NN
required_VBN
for_IN
HIV_NN
transcription_NN
,_,
and_CC
ultimately_RB
to_TO
cell_NN
death_NN
._.

Purified_VBN
bcl-2_NN
is_VBZ
cleaved_VBN
by_IN
HIV_NN
protease_NN
between_IN
phenylalanine_NN
112_CD
and_CC
alanine_NN
113_CD
._.

The_DT
results_NNS
suggest_VBP
a_DT
new_JJ
option_NN
for_IN
HIV_NN
gene_NN
therapy_NN
;_:
bcl-2_NN
muteins_NNS
that_WDT
have_VBP
noncleavable_JJ
alterations_NNS
surrounding_VBG
the_DT
HIV_NN
protease_NN
cleavage_NN
site_NN
._.

